Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autolus Therapeutics PLC

2.52
-0.1200-4.55%
Post-market: 2.570.0500+1.98%19:12 EDT
Volume:1.12M
Turnover:2.88M
Market Cap:670.68M
PE:-2.82
High:2.66
Open:2.65
Low:2.50
Close:2.64
Loading ...

Autolus Therapeutics plc to Release Second Quarter 2025 Financial Results

Reuters
·
24 Jul

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
21 Jul

Top Premarket Gainers

MT Newswires Live
·
21 Jul

European Commission Grants Marketing Authorization for Autolus Therapeutics' CAR T Therapy AUCATZYL for Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Reuters
·
21 Jul

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
16 Jul

Autolus Therapeutics Announces Inducement Grants

Reuters
·
16 Jul

Autolus Therapeutics Announces Inducement Stock Option Plan for New Employees Under Nasdaq Rule

Reuters
·
16 Jul

European Equities Traded in the US as ADRs Edge Up in Monday Trading

MT Newswires Live
·
14 Jul

European Equities Traded in the US as American Depositary Receipts Advance in Tuesday Trading

MT Newswires Live
·
08 Jul

European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading

MT Newswires Live
·
07 Jul

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
02 Jul

Autolus Therapeutics Passes All AGM Resolutions

TIPRANKS
·
27 Jun

Autolus Therapeutics plc Held Annual General Meeting

Reuters
·
27 Jun

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

MT Newswires Live
·
25 Jun

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

MT Newswires Live
·
18 Jun

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
17 Jun

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
16 Jun

Autolus Therapeutics Price Target Maintained With a $10.00/Share by Needham

Dow Jones
·
13 Jun

Autolus Therapeutics Announces Promising Long-Term Data for Obe-Cel in R/R B-ALL at 2025 EHA Congress

Reuters
·
12 Jun

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

MT Newswires Live
·
11 Jun